Synutra International, Inc.
US Elections Calendar ~ Pervez Musharraf ~ Iftikhar Muhammad Chaudhry ~ Other International News
Home / International News / Press Releases / July 18, 2008
Synutra Announces Postponement of Proposed Offering

Top News

Karnataka High Court orders Ramoji Rao to appear in Ballari Court

CCEA approves scheme on National Mission on Medicinal Plants

Magnets could keep sharks at bay!

Pammie was first choice for X-Files lead role!

Chidambaran says government to speed up reforms

ICC chief Haroon Lorgat to meet the media in Colombo

Bossy parents cause older teens to indulge in more sex

Aussies turning in droves to alternative therapies

Synutra Announces Postponement of Proposed Offering

QINGDAO, China and ROCKVILLE, Md., July 18 /Xinhua-PRNewswire/ -- Synutra International, Inc. (Nasdaq: SYUT, "Synutra"), a leading infant formula company in China, and a producer, marketer and seller of nutritional products for infants, children and adults, announced today that it has postponed its proposed public offering of its common stock indefinitely.

"Due to current stock market conditions, our board has determined it is in the best interest of our stockholders to postpone the offering," said Liang Zhang, Chairman and CEO of Synutra International, Inc.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. A copy of the registration statement for this offering may be obtained at http://www.sec.gov . These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.

About Synutra International, Inc.

Synutra, through its operating subsidiaries in China, is principally engaged in the development, production, distribution and sales of dairy-based nutritional products across the People's Republic of China. It offers its products for infants, children, adults, pregnant women and nursing mothers under the "Sheng Yuan" or "Synutra" master brand and several sub-brands, including "Super," "U-Smart" and "U-Strong." For more information, please contact Weiguo Zhang of Synutra, Inc. (301 840 3888, wzhang@synutra.com), Brian Rafferty of Taylor Rafferty (212 889 4350, synutra@taylor-rafferty.com) or visit: http://www.synutra.com .

The information contained herein includes statements, estimates, projections, guidance or outlook that constitute "forward-looking" statements as defined under U.S. federal securities laws. Generally the words "believe," "expect," "intend," "estimate," "anticipate," "plan," "project," "will" and similar expressions, identify forward-looking statements, which generally are not historical in nature. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward- looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward looking statements if they comply with the requirements of the Act.

    For further information, please contact:

     Mr. Weiguo Zhang,
     Synutra, Inc.
     Tel:   +1-301-840-3888
     Email: wzhang@synutra.com

     Mr. Brian Rafferty,
     Taylor Rafferty
     Tel:   +1-212-889-4350
     Email: synutra@taylor-rafferty.com

SOURCE Synutra International, Inc.

International News / Press Release source: PR Newswire
Copyright PR Newswire. All Rights Reserved.

International Business News / Press Releases

China Marine Penetrates New Markets in Shanghai and Guangdong Province and Launches Three New Snack Foods Market-wide
PR Newswire

Suntech to Announce Second Quarter 2008 Financial Results on August 20, 2008
PR Newswire

China Agritech Delivers Fertilizer Shipment to Egypt
PR Newswire

China Wind Systems, Inc. Issues Guidance for Second Quarter and Full Year 2008
PR Newswire

CCID Consulting Forecasts Compound Growth Rate for China's Broadcasting Mobile TV Output
PR Newswire

International Health News / Press Releases

Pharmasset Announces Consummation of $24.18 Million Registered Direct Offering of Common Stock
PR Newswire

Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
PR Newswire

American Stress Levels Reaching an All-Time High
PR Newswire

China Information Security Technology, Inc. Expands PGIS Solution Set With First 120 Emergency Medical Service (EMS) System Contract Win in Shenzhen City
PR Newswire

Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
PR Newswire